Skip to main content

Inovio Pharmaceuticals, Inc. (INO)

NASDAQ: INO · IEX Real-Time Price · USD
7.83
+0.07 (0.90%)
After-hours:Sep 24, 2021 7:46 PM EDT
7.76
-0.27 (-3.36%)
At close: Sep 24, 4:00 PM
Market Cap1.63B
Revenue (ttm)6.46M
Net Income (ttm)-141.71M
Shares Out209.56M
EPS (ttm)-0.75
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,411,559
Open7.98
Previous Close8.03
Day's Range7.76 - 8.04
52-Week Range5.81 - 19.00
Beta0.62
AnalystsHold
Price Target13.22 (+70.4%)
Est. Earnings DateNov 8, 2021

About INO

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon optimized plasmids that have ability to help break the immune system's tolerance of cancerous or infected cells and facilitate cross-strain protection against unmatched and matched pathogen variants. The company is involved in conducting an...

IndustryBiotechnology
IPO DateFeb 12, 1998
CEOJong Kim
Employees262
Stock ExchangeNASDAQ
Ticker SymbolINO
Full Company Profile

Financial Performance

In 2020, INO's revenue was $7.41 million, an increase of 80.24% compared to the previous year's $4.11 million. Losses were -$166.41 million, 39.4% more than in 2019.

Financial Statements

Analyst Forecast

According to 10 analysts, the average rating for INO stock is "Hold." The 12-month stock price forecast is 13.22, which is an increase of 70.36% from the latest price.

Price Target
$13.22
(70.36% upside)
Analyst Consensus: Hold

News

INOVIO Receives Regulatory Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO...

PLYMOUTH MEETING, Pa., Sept. 22, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infecti...

4 days ago - PRNewsWire

5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch

Their vaccines could be late to the party. But the stocks might still be big winners.

Other symbols:DVAXGSKNVAXSNY
1 week ago - The Motley Fool

5 Stocks With 195% to 467% Upside, According to Wall Street

If these high-water price targets come to fruition, investors will be all smiles.

Other symbols:AMRNICPTPLUGZGNX
2 weeks ago - The Motley Fool

INOVIO to Present at Upcoming Investor Conferences in September

PLYMOUTH MEETING, Pa. , Sept. 1, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infecti...

3 weeks ago - PRNewsWire

Why Inovio Stock Is Jumping Today

The vaccine maker received some good news from Brazil.

1 month ago - The Motley Fool

Inovio Pharmaceuticals Stock Nears End Of Technical Pattern

Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the global Phase 3 segment o...

1 month ago - Benzinga

Inovio To Start Global Late-Stage COVID-19 Vaccine Trial

The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-4800, DNA COVID-19 vaccine candidate. Related ...

1 month ago - Benzinga

INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800

PLYMOUTH MEETING, Pa., Aug. 26, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectio...

1 month ago - PRNewsWire

5 Popular Stocks Billionaires Couldn't Sell Fast Enough in the Second Quarter

These widely held stocks were on successful money managers' chopping blocks in Q2.

Other symbols:BIDUEDUGMEPLUG
1 month ago - The Motley Fool

Why Dynavax, Novavax, and Inovio Stocks Sank This Week

Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.

Other symbols:DVAXNVAX
1 month ago - The Motley Fool

3 Scary COVID Stocks to Avoid

Our Fool roundtable picks three COVID stocks they think are dangerous at these prices.

Other symbols:NVAXPLNT
1 month ago - The Motley Fool

Watch Out: Inovio Pharmaceuticals Is Heating Up

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta variant has been spreadi...

1 month ago - Benzinga

Former Penny Stocks To Watch After Merck's (MRK) Latest FDA Win

Merck's FDA and coronavirus vaccine news sparked momentum in biotech stocks today. Here are 4 to watch.

Other symbols:DVAXGTBPIBBXLV
1 month ago - PennyStocks

Why Inovio Pharmaceuticals Is Plunging Today

Solid business developments did not please investors.

1 month ago - The Motley Fool

Inovio Pharmaceuticals (INO) Reports Q2 Loss, Misses Revenue Estimates

Inovio (INO) delivered earnings and revenue surprises of -56.00% and -1.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Recap: Inovio Pharmaceuticals Q2 Earnings

Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year over year to ($0.39), ...

1 month ago - Benzinga

INOVIO Reports Second Quarter 2021 Financial Results

PLYMOUTH MEETING, Pa., Aug. 9, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people from i...

1 month ago - PRNewsWire

Why Inovio Stock Is Jumping Today

Chinese regulators approved the initiation of two new clinical studies featuring Inovio's COVID-19 vaccine candidate, INO-4800.

1 month ago - The Motley Fool

INOVIO and Advaccine Receive Regulatory Allowance for Two Heterologous Prime-Boost Clinical Trials in China Using INO...

PLYMOUTH MEETING, Pa. and SUZHOU, China, Aug. 9, 2021 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peo...

1 month ago - PRNewsWire

What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock?

Its vaccine candidate might be too far behind to matter.

1 month ago - The Motley Fool

INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), ...

PLYMOUTH MEETING, Pa., Aug. 4, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases...

1 month ago - PRNewsWire

Analysts Estimate Inovio Pharmaceuticals (INO) to Report a Decline in Earnings: What to Look Out for

Inovio (INO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Former Biotech Penny Stocks Seeing Explosive Moves In 2021

Are penny stocks worth it? Take a look at these 3 seeing explosive moves this year.

Other symbols:ANVSGTBP
1 month ago - PennyStocks

Can Last Year's Biggest Vaccine Stocks Crush the Market Again?

These players delivered triple- and quadruple-digit gains.

1 month ago - The Motley Fool

INOVIO to Report Second Quarter 2021 Financial Results on August 9, 2021

PLYMOUTH MEETING, Pa., July 26, 2021 /PRNewswire/ -- INOVIO (NASDAQ: INO) announced today that second quarter 2021 financial results will be released after the market close on August 9, 2021.

2 months ago - PRNewsWire